Skip to main content

Advertisement

Table 1 Reported antimalarial treatment practices of health care providers in six study sites of three states/regions, Myanmar (n = 32)

From: Access to primaquine in the last mile: challenges at the service delivery points in pre-elimination era, Myanmar

Health care Treatment Study region A Study region B Study region C Total
Confirmed uncomplicated falciparum malaria
Public sector (n = 24) ACT + PQ (correct dose and course) 6/6 (100%) 10/10 (100%) 8/8 (100%) 24/24 (100%)
Artesunate 2 tds × 3 days 0 0 0 0
Private sector (n = 8) ACT + PQ (correct dose and course) 1/2 (50%) 1/2 (50%) 3/4 (75%) 5/8 (65%)
Confirmed vivax malaria
Public sector (n = 24) CQ + PQ (correct dose and course) 8/8 (100%) 5/5 (100%) 11/11 (100%) 24/24 (100%)
CQ only 0 0 0 0
Private sector (n = 8) CQ + PQ (correct dose and course) 0/3 0/4 0/1 0/8
CQ only 0 0 0 0
  1. ACT artemisinin combination treatment, PQ primaquine, CQ chloroquine, tds three times a day